ApoA-1与HDL-C作为心血管风险标志物的对比
Selin Bilgic1, Karol Pencina2, Michael Pencina3
1Mike and Valeria Rosenbloom Centre for Cardiovascular Prevention, Department of Medicine, McGill University Health Centre, 1001 Decarie Blvd, Montreal, Quebec H4A 3J1, Canada (Bilgic, Dr K. Pencina, Dr M. Pencina, Dufresne, Thanassoulis, and Sniderman).
Journal of clinical lipidology
|March 14, 2026
概括
阿波脂蛋白A-1 (apoA-1) 和高密度脂蛋白胆固醇 (HDL-C) 与动脉样硬化心血管疾病 (ASCVD) 风险有相似的关联. 在分析后,apoA-1解释了比甘油三更多的风险,表明HDL-C.
科学领域:
- 心血管研究研究心血管研究
- 生物标记分析 生物标记分析
- 脂质代谢 脂质代谢是什么
背景情况:
- 关于阿波利波蛋白A-1 (apoA-1) 与高密度脂蛋白胆固醇 (HDL-C) 在预测动脉样硬化心血管疾病 (ASCVD) 风险方面的相对重要性存在相互矛盾的数据.
- 了解这些标记物的确切作用对于准确的风险评估至关重要.
研究的目的:
- 直接比较apoA-1和HDL-C对心血管风险的预测能力.
- 在ASCVD风险预测中研究apoA-1和HDL-C之间的相互作用.
主要方法:
- 使用了与考克斯比例危险模型的剩余不一致性分析.
- 分析了291,995名英国生物库参与者的数据,平均随访时间为11年.
- 进行了相互作用试验,并将HDL-C分解为apoA-1,log-triglyceride和残留成分.
主要成果:
- 无论是apoA-1还是HDL-C都显示出与ASCVD风险的类似关联 (HR=0.85).
- 在apoA-1和HDL-C之间观察到显著的相互作用,改变了它们的个体效应.
- 在分解后,apoA-1占HDL-C作用的最大部分,比log-triglycerides更多.
结论:
- HDL-C和apoA-1与ASCVD风险相关,具有相等强度,其影响相互修改.
- 分解分析表明,apoA-1与甘油三相比,对HDL-C的风险预测能力具有更强的决定性.
- 这些观察结果表明,甘油三水平可能不仅仅决定了HDL和心血管风险之间的关系.
相关概念视频
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
688
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
688
Atherosclerosis III: Management
562
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
562
Coronary Artery Disease IV: Preventive Measures
798
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
798
Atherosclerosis I: Introduction
1.8K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.8K
Coronary Artery Disease I: Introduction
1.5K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.5K
Blood Studies for Cardiovascular System III: Serum Lipid Profile
745
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
745


